Antitubercular drug resistance in four healthcare facilities in north India

Journal of Health, Population and Nutrition

Volumn 29, Issue 6, 2011, Pages 583-592

  Gupta, Anamika ^a   Mathuria, Jitendra Prasad ^b   Singh, Surya Kumar ^a   Gulati, Anil Kumar ^a   Anupurba, Shampa ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b MANIPAL COLLEGE OF MEDICAL SCIENCES   (Nepal)

Author keywords

Acquired immunodeficiency syndrome; Antitubercular drugs; Diabetes; Drug resistance; HIV; India; Tuberculosis

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; MYCOBACTERIUM TUBERCULOSIS;

TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ARTICLE; COMORBIDITY; DRUG EFFECT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; LUNG TUBERCULOSIS; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RISK FACTOR;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; COMORBIDITY; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HIV SEROPOSITIVITY; HUMANS; INDIA; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RISK FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84857478161     PISSN: 16060997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Aziz MA, Wright A, Laszlo A, De Muynck A, Portaels F, Van Deun A et al. Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis. Lancet 2006;368:2142-54.
2. World Health Organization. Stop TB partnership, 2009 update: tuberculosis facts. Geneva: World Health Organization, 2009. 1 p. (http://www.who.int/tb/publications/2009/tbfactsheet_2009update_ one_page.pdf, accessed on 15 December 2009).
3. World Health Organization. Global tuberculosis control: epidemiology, strategy, financing. Geneva: World Health Organization, 2009. 78 p. (WHO report no. HTM/TB/2009.411).
4. World Health Organization. TB/HIV: a clinical manual. Geneva: World Health Organization, 2004. 210 p.(http://libdoc.who.int/publications/2004/9241546344.pdf, accessed on 25 May 2008).
5. Swaminathan S, Ramachandran R, Baskaran G, Paramasivan CN, Ramanathan U, Venkatesan P et al. Risk of development of tuberculosis in HIV infected patients. Int J Tuberc Lung Dis 2000;4:839-44.
6. Tatar D, Senol G, Alptekin S, Karakurum C, Aydin M, Coskunol I. Tuberculosis in diabetics: features in an endemic area. Jpn J Infect Dis 2009;62:423-7.
7. World Health Organization. Anti-tuberculosis drug resistance in the world. Geneva: World Health Organization, 2008:25-6. (Report no. 4).
8. World Health Organization. Global Task Force outlines measures to combat XDR-TB worldwide. Notes for the media. Geneva: World Health Organization, 2006. (http://www.who.int/mediacentre/news/notes/2006/np29/en/index.html, accessed on 30 November 2007).
9. Shenoi S, Friedland G. Extensively drug-resistant tuberculosis: a new face to an old pathogen. Annu Rev Med 2009;60:307-20.
10. Espinal MA, Laszlo A, Simonsen L, Boulahbal F, Kim SJ, Reniero A et al. Global trends in resistance to antituberculosis drugs. N Engl J Med 2001;344:1294-1303.
11. Prasad R. MDR-TB: current status. Indian J Tuberc 2005;52:121-31.
12. Pablos -Mendez PA, Raviglione MC, Laszlo A, Binkin N, Rieder HL, Bustreo F et al. Global surveillance for anti-tuberculosis drug resistance 1994-97. N Engl J Med 1998;338:1641-9.
13. Antonucci G, Girardi E, Raviglione MC, Ippolito G. Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA). JAMA 1995;274:143-8.
14. Prammananan T, Arjratanakool W, Chaiprasert A, Tingtoy N, Leechawengwong M, Asawapokee N et al. Second-line drug susceptibilities of Thai multidrug-resistant Mycobacterium tuberculosis isolates. Int J Tuberc Lung Dis 2005;9:216-9.
15. Canetti G, Froman S, Grosset J, Hauduroy P, Langerova M, Mahler HT et al. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull World Health Organ 1963;9:565-78.
16. Kent PT, Kubica GP. Public health mycobacteriology: a guide for the level III laboratory. Atlanta, GA: Centers for Disease Control and Prevention, 1985:96-103.
17. Centro Panaonosis. Tuberculosis bacteriology. Buenos Aires: Centro Panamericano de Zoonosis, 1988. (Technical note 11).
18. Canetti G, Fox W, Khomenko A, Mahler HT, Menon NK, Mitchison DA et al. Advances in techniques of testing mycobacterial drug sensitivity and the use of sensitivity tests in tuberculosis control programs. Bull World Health Organ 1969;41:21-43.
19. Toungoussova OS, Caugant DA, Sandven P, Mariandyshev AO, Bjune G. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Arkangelsk, Russia. Int J Tuberc Lung Dis 2002;6:5:406-14.
20. Chauhan LS. Drug resistant TB-RNTCP response (P.K. Sen-TAI Gold Medal oration delivered at the 62nd National Conference on Tuberculosis & Chest Diseases held in New Delhi from 14th to 16th December 2007). Indian J Tuberc 2008;55:5-8.
21. Ormerod LP. Multidrug-resistant tuberculosis (MDRTB): epidemiology, prevention and treatment. Br Med Bull 2005;73-74:17-24.
22. D'souza DT, Mistry NF, Vira TS, Dholakia Y, Hoffner S, Pasvol G et al. High levels of multidrug resistant tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an urban metropolis (Mumbai) in western India. BMC Public Health 2009;9:211.
23. Bonnet M, Sizaire V, Kebede Y, Janin A, Doshetov D, Mirzoian B et al. Does one size fit all? Drug resistance and standard treatments: results of six tuberculosis programmes in former Soviet countries. Int J Tuberc Lung Dis 2005;9:1147-54.
24. World Health Organization. Global tuberculosis control 2008: surveillance, planning, financing. Geneva: World Health Organization, 2008. 294 p. (http:// www.who.int/tb/publications/global_report/2008/ pdf/fullreport.pdf, accessed on 15 December 2008).
25. Zignol M, Hosseini MS, Wright A, Weezenbeek CL, Nunn P, Watt CJ et al. Global incidence of multidrugresistant tuberculosis. J Infect Dis 2006;194:479-85.
26. Djuretic T, Herbert J, Drobniewski F, Yates M, Smith EG, Magee JG et al. Antibiotic resistant tuberculosis in the United Kingdom: 1993-1999. Thorax 2002; 57:477-82.
27. Caminero JA. Treatment of multidrug-resistant tuberculosis: evidence and controversies. Int J Tuberc Lung Dis 2006;10:829-37.
28. Shamaei M, Marjani M, Chitsaz E, Kazempour M, Esmaeili M, Farnia P et al. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran-eight years of surveillance. Int J Infect Dis 2009;13:236-40
29. Cohn DL, Bustreo F, Raviglione MC. Drug-resistant tuberculosis; review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease. Clin Infect Dis 1997;1:S121-30.
30. Al-Tawfiq JA, Al-Muraikhy AA, Abed MS. Susceptibility pattern and epidemiology of Mycobacterium tuberculosis in a Saudi Arabian hospital: a 15-year study from 1989 to 2003. Chest 2005;128:3229-32.
31. Rahman M, Kamal SMS, Mohammed FR, Alam MB, Ahasan HN. Antituberculosis drug resistance pattern among different category of tuberculosis patients. J Med 2009;10:45-7.
32. Park SK, Kim JH, Kang H, Cho JS, Smego RA, Jr. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. Int J Infect Dis 2009;13:170-5.
33. Prasad R, Verma SK, Kumar Y, Nag VL, Tripathi AK. A clinico-radiological study of patients of tuberculosis with HIV co-infection. Curr Med Trend 2006;10:1971-7.
34. Sharma SK, Mohan A. Coinfection of human immunodeficiency virus (HIV) and tuberculosis: Indian perspective. Indian J Tuberc 2004;51:5-16.
35. Dabrowska MM, Pogorzelska J, Parfieniuk A, Siwak E, Wiercińska-Drapało A. [Tuberculosis and HIV infection- main diagnostic and therapeutic problems]. Polski Merkuriusz Lekarski 2007;135:212-4. [Polish]
36. Ponce-De-Leon A, Garcia-Garcia Md Mde L, Garcia-Sancho MC, Gomez-Perez FJ, Valdespino-Gomez JL, Olaiz-Fernandez G et al. Tuberculosis and diabetes in southern Mexico. Diab Care 2004;27:1584-90.
37. Young F, Critchley J, Unwin N. Diabetes & tuberculosis: a dangerous liaison & no white tiger. Indian J Med Res 2009;130:1-4.
38. Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis 2009;9:737-46.
39. Stevenson CR, Forouhi NG, Roglic G, Williams BG, Lauer JA, Dye C et al. Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. BMC Public Health 2007;7:234.